| Company | Date | Position | Consensus β | Price Target β | 1-Yr Return | vs S&P 500 β |
|---|---|---|---|---|---|---|
|
ZTS
Zoetis
|
Oct 16, 2026 | HOLD |
Buy
+43.1% avg upside
25 analysts
|
$74.00
9.60% Downside
|
+2.8% | Β· |
|
IDXX
Idexx Laboratories
|
Oct 15, 2026 | BUY |
Buy
+29.6% avg upside
19 analysts
|
$740.00
30.43% Upside
|
+3.4% | Β· |
|
ELAN
Elanco Animal Health
|
Oct 15, 2026 | BUY |
Strong Buy
+38.1% avg upside
20 analysts
|
$32.00
40.43% Upside
|
-4.2% | Β· |
|
AMRX
Amneal Pharmaceuticals
|
Aug 10, 2026 | BUY |
Strong Buy
-5.9% avg upside
19 analysts
|
$21.00
3.22% Upside
|
+13.0% | Β· |
|
VTRS
Viatris
|
Oct 22, 2025 | HOLD |
Buy
+28.8% avg upside
22 analysts
|
$12.00
35.15% Downside
|
+85.5% | Β· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.